Wolfe Research Upgrades Kymera Therapeutics (KYMR) to Outperform

September 10, 2026 5:33 AM

Wolfe Research analyst Andy Chen upgraded Kymera Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found